113 related articles for article (PubMed ID: 11039850)
1. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays.
Majluf-Cruz A; Manns JM; Uknis AB; Yang X; Colman RW; Harris RB; Frazier W; Lawler J; DeLa Cadena RA
J Lab Clin Med; 2000 Oct; 136(4):292-302. PubMed ID: 11039850
[TBL] [Abstract][Full Text] [Related]
2. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
[TBL] [Abstract][Full Text] [Related]
3. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1.
Voland C; Serre CM; Delmas P; Clézardin P
J Bone Miner Res; 2000 Feb; 15(2):361-8. PubMed ID: 10703939
[TBL] [Abstract][Full Text] [Related]
4. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
5. Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins.
Qabar AN; Bullock J; Matej L; Polverini P
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):147-53. PubMed ID: 10657251
[TBL] [Abstract][Full Text] [Related]
6. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254.
DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW
Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 binds to polyhistidine with high affinity and specificity.
Vanguri VK; Wang S; Godyna S; Ranganathan S; Liau G
Biochem J; 2000 Apr; 347(Pt 2):469-73. PubMed ID: 10749676
[TBL] [Abstract][Full Text] [Related]
8. Platelet thrombospondin interactions with human high and low molecular weight kininogens.
DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW
Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1.
Guo N; Zabrenetzky VS; Chandrasekaran L; Sipes JM; Lawler J; Krutzsch HC; Roberts DD
Cancer Res; 1998 Jul; 58(14):3154-62. PubMed ID: 9679984
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
[TBL] [Abstract][Full Text] [Related]
11. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.
Isenberg JS; Calzada MJ; Zhou L; Guo N; Lawler J; Wang XQ; Frazier WA; Roberts DD
Matrix Biol; 2005 Apr; 24(2):110-23. PubMed ID: 15890262
[TBL] [Abstract][Full Text] [Related]
12. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.
Wang S; Herndon ME; Ranganathan S; Godyna S; Lawler J; Argraves WS; Liau G
J Cell Biochem; 2004 Mar; 91(4):766-76. PubMed ID: 14991768
[TBL] [Abstract][Full Text] [Related]
13. An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs.
McDonald JF; Dimitry JM; Frazier WA
Biochemistry; 2003 Aug; 42(33):10001-11. PubMed ID: 12924949
[TBL] [Abstract][Full Text] [Related]
14. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
15. A 16-kDa fragment of collagen type XIV is a novel neutrophil chemotactic factor purified from rat granulation tissue.
Nakagawa H; Takano K; Kuzumaki H
Biochem Biophys Res Commun; 1999 Mar; 256(3):642-5. PubMed ID: 10080952
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin stimulates motility of human neutrophils.
Mansfield PJ; Boxer LA; Suchard SJ
J Cell Biol; 1990 Dec; 111(6 Pt 2):3077-86. PubMed ID: 2269666
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
[TBL] [Abstract][Full Text] [Related]
18. Peptide probe study of the role of interaction between the cytoplasmic and transmembrane domains of the ryanodine receptor in the channel regulation mechanism.
Hamada T; Bannister ML; Ikemoto N
Biochemistry; 2007 Apr; 46(14):4272-9. PubMed ID: 17361990
[TBL] [Abstract][Full Text] [Related]
19. The 33-kDa platelet alpha-granule membrane protein (GMP-33) is an N-terminal proteolytic fragment of thrombospondin.
Damas C; Vink T; Nieuwenhuis HK; Sixma JJ
Thromb Haemost; 2001 Sep; 86(3):887-93. PubMed ID: 11583323
[TBL] [Abstract][Full Text] [Related]
20. Activation of human neutrophils increases thrombospondin receptor expression.
Suchard SJ; Boxer LA; Dixit VM
J Immunol; 1991 Jul; 147(2):651-9. PubMed ID: 1712815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
